Trial Profile
Phase II Open Study to Evaluate Safety and Efficacy of AS101 for the Treatment of Thrombocytopenia in Solid Tumor
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Apr 2014
Price :
$35
*
At a glance
- Drugs AS 101 (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- Sponsors BioMAS
- 09 Apr 2014 New trial record
- 20 Jun 2011
- 09 Nov 2009